In hyperglycemia-associated Phase I retinopathy mice, FGF21 (PF-05231023) decreased TFEB phosphorylation at serine 142 (Fig. 5), suggesting activation of the TFEB pathway by FGF21. This evidence concerns the gene TFEB and retinal disorder.